Sd. Hudnall et al., Hydrocortisone activation of human herpesvirus 8 viral DNA replication andgene expression in vitro., TRANSPLANT, 67(5), 1999, pp. 648-652
Background, Patients undergoing chronic steroid therapy for organ transplan
tation are at increased risk for development of human herpes virus 8(HHV-8)
associated Kaposi's sarcoma (KS), It has also keen reported that following
steroid withdrawal, KS lesions often undergo partial or complete regression
.
Methods. We have examined the effect of corticosteroid treatment on HHV-8 r
eplication, gene expression, and lytic protein expression in BCBL-1 cells i
n vitro. BCBL-1 cells were collected after culture for 24-72 hr with hydroc
ortisone (HC) 1-5 mu M, phorbol ester 20 ng/ml (positive control), and cult
ure medium only (negative control). HHV-8 genomic conformation was examined
by Gardella gel analysis. mRNA expression of viral cyclin (v-Cyc), viral B
cl-2 (v-Bcl-2), viral macrophage inflammatory protein-I (v-MIP-I), viral in
terferon regulatory factor-1 (v-IRF-1), and viral tegument protein (TP) was
examined by RT-PCR Southern blot, Viral protein expression within the cell
s was examined by indirect immunofluorescence using 5 different HHV-8 posit
ive antisera from 4 renal transplant recipients and 1 patient with classic
KS.
Results. Gardella gel analysis revealed that HC induced an accumulation of
the linear replicative genomic form of the virus in a time-dependent fashio
n. Southern blot analysis of the RT-PCR products revealed that HC induced i
ncreased expression of v-IRF-1, v-Bcl-2, and TP mRNA, with little discernib
le effect on v-Cyc, and V-MIP-I, Immunofluorescence revealed that HC induce
d increased numbers of cells expressing lytic antigens,
Conclusions. These data indicate that hydrocortisone acts directly on BCBL-
1 cells to activate the lytic cycle of HHV-8 and provide further support fo
r the hypothesis that HHV-8 is activated in corticosteroid-treated immunoco
mpromised patients.